{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Acute+Hepatitis", "query": { "condition": "Acute Hepatitis" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 36, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Acute+Hepatitis&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-07-22T11:39:23.949Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01471028", "title": "Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acute Alcoholic Hepatitis" ], "interventions": [ { "name": "ELAD treatment", "type": "BIOLOGICAL" }, { "name": "Standard of care (Control)", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Vital Therapies, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 203, "start_date": "2013-02", "completion_date": "2015-08", "has_results": true, "last_update_posted_date": "2019-02-15", "last_synced_at": "2026-07-22T11:39:23.949Z", "location_count": 35, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Little Rock, Arkansas + 25 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Coronado", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01471028" }, { "nct_id": "NCT00001119", "title": "Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Tetanus Toxoid Vaccine", "type": "BIOLOGICAL" }, { "name": "Indinavir sulfate", "type": "DRUG" }, { "name": "Lamivudine/Zidovudine", "type": "DRUG" }, { "name": "Ritonavir", "type": "DRUG" }, { "name": "Abacavir sulfate", "type": "DRUG" }, { "name": "Amprenavir", "type": "DRUG" }, { "name": "Efavirenz", "type": "DRUG" }, { "name": "Hepatitis B Vaccine (Recombinant)", "type": "BIOLOGICAL" }, { "name": "Lamivudine", "type": "DRUG" }, { "name": "Zidovudine", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 288, "start_date": "1999-10", "completion_date": null, "has_results": false, "last_update_posted_date": "2011-03-02", "last_synced_at": "2026-07-22T11:39:23.949Z", "location_count": 11, "location_summary": "San Francisco, California • Chicago, Illinois • Boston, Massachusetts + 6 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00001119" }, { "nct_id": "NCT02128217", "title": "Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HIV-1 Infection", "Hepatitis" ], "interventions": [ { "name": "Sofosbuvir", "type": "DRUG" }, { "name": "Ribavirin", "type": "DRUG" }, { "name": "Ledipasvir/Sofosbuvir", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 44, "start_date": "2014-05-30", "completion_date": "2017-05-09", "has_results": true, "last_update_posted_date": "2018-04-27", "last_synced_at": "2026-07-22T11:39:23.949Z", "location_count": 12, "location_summary": "San Diego, California • San Francisco, California • Washington D.C., District of Columbia + 7 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02128217" }, { "nct_id": "NCT02612428", "title": "Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects w/ AILD", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acute Alcoholic Hepatitis" ], "interventions": [ { "name": "ELAD System", "type": "BIOLOGICAL" }, { "name": "Standard of Care (Control)", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Vital Therapies, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 151, "start_date": "2016-01", "completion_date": "2018-09", "has_results": true, "last_update_posted_date": "2019-01-25", "last_synced_at": "2026-07-22T11:39:23.949Z", "location_count": 21, "location_summary": "Little Rock, Arkansas • Coronado, California • Palo Alto, California + 16 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Coronado", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02612428" }, { "nct_id": "NCT00005936", "title": "Collection of Liver Tissue for Virologic Studies", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Virus Disease" ], "interventions": [], "intervention_types": [], "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 50, "start_date": "2000-06", "completion_date": "2002-03", "has_results": false, "last_update_posted_date": "2008-03-04", "last_synced_at": "2026-07-22T11:39:23.949Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00005936" }, { "nct_id": "NCT06285253", "title": "miroliverELAP® for the Treatment of Acute Liver Failure: A Phase 1 Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Acute Liver Failure", "Acute Liver Injury, Drug Induced", "Acute on Chronic Liver Failure (ACLF)", "Acute Alcoholic Hepatitis" ], "interventions": [ { "name": "miroliverELAP treatment", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "Miromatrix Medical Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 10, "start_date": "2024-10-05", "completion_date": "2026-01-22", "has_results": false, "last_update_posted_date": "2026-03-06", "last_synced_at": "2026-07-22T11:39:23.949Z", "location_count": 8, "location_summary": "Chicago, Illinois • Ann Arbor, Michigan • Minneapolis, Minnesota + 5 more", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06285253" }, { "nct_id": "NCT04846010", "title": "Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Sequelae of; Infection", "Post Infection Glomerulonephritis", "Post-Infectious Peripheral Neuralgia", "Post-Infectious Disorder (Disorder)", "Post-Infectious Arthritis", "Post-Infectious Polyneuritis", "Post-Infectious Parkinsonism", "Post-Infectious Hypothyroidism", "Post Infectious Osteoarthritis", "Anxiety Disorders", "Depression", "Depression, Anxiety", "Depression, Bipolar", "Insomnia", "GERD", "Gastro Esophageal Reflux", "Hepatitis", "Glomerulonephritis" ], "interventions": [ { "name": "PurWet", "type": "COMBINATION_PRODUCT" }, { "name": "FurFat", "type": "COMBINATION_PRODUCT" }, { "name": "PurApo", "type": "COMBINATION_PRODUCT" }, { "name": "PurPhl", "type": "COMBINATION_PRODUCT" }, { "name": "PurClo", "type": "COMBINATION_PRODUCT" }, { "name": "PurInf", "type": "COMBINATION_PRODUCT" }, { "name": "Smoliv", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "All Natural Medicine Clinic, LLC", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 2000, "start_date": "2021-03-01", "completion_date": "2022-10-01", "has_results": false, "last_update_posted_date": "2021-05-26", "last_synced_at": "2026-07-22T11:39:23.949Z", "location_count": 1, "location_summary": "Rockville, Maryland", "locations": [ { "city": "Rockville", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT04846010" }, { "nct_id": "NCT02552901", "title": "Cardiox Liver Function Test Pivotal Trial", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hepatic Failure", "Liver Failure" ], "interventions": [ { "name": "0.1 mg/kg ICG Dose", "type": "DRUG" }, { "name": "0.5 mg/kg ICG dose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cardiox Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 0, "start_date": "2015-11", "completion_date": "2016-05", "has_results": false, "last_update_posted_date": "2016-01-15", "last_synced_at": "2026-07-22T11:39:23.949Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02552901" }, { "nct_id": "NCT04042740", "title": "Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hepatitis C Infection", "HIV Infection" ], "interventions": [ { "name": "Glecaprevir/Pibrentasvir (G/P)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 45, "start_date": "2019-11-20", "completion_date": "2023-08-22", "has_results": true, "last_update_posted_date": "2024-07-11", "last_synced_at": "2026-07-22T11:39:23.949Z", "location_count": 11, "location_summary": "San Diego, California • San Francisco, California • Aurora, Colorado + 6 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT04042740" }, { "nct_id": "NCT04903626", "title": "Study to Evaluate Adverse Events and Change in Disease Activity in Adult and Adolescent Participants With Acute Hepatitis C Virus (HCV) Infection on Treatment With Oral Tablets of Glecaprevir (GLE)/Pibrentasvir (PIB)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hepatitis C Virus (HCV)" ], "interventions": [ { "name": "Glecaprevir/Pibrentasvir (GLE/PIB)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 286, "start_date": "2021-08-24", "completion_date": "2024-09-17", "has_results": true, "last_update_posted_date": "2025-04-06", "last_synced_at": "2026-07-22T11:39:23.949Z", "location_count": 37, "location_summary": "Chandler, Arizona • Peoria, Arizona • Little Rock, Arkansas + 31 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Chula Vista", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04903626" } ] }